Fa. Abbott Laboratories GmbH in Neustadt a. R. bei Hannover (Photo by Rust/ullstein bild via Getty Images) Quidel, a company that makes diagnostic products for infectious diseases and other conditions ...

Quest also buried the hatchet with Oxford Immunotec, completing an acquisition of its U.S. laboratory services business and launching a collaboration after the settling of a patent infringement ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Quest Diagnostics (NYSE:DGX) is in focus as testing volumes shapes the outlook. Explore the key themes and milestones to watch next.

CEO and President Jim Davis said the diagnostic testing company is exceeding the growth framework it outlined at its prior investor day, driven largely by organic growth, consumer-health demand and ...

Quest Diagnostics has introduced a new flow cytometry measurable residual disease (MRD) blood test for myeloma, a cancer arising from abnormal plasma cells. The test aims to enhance ultra-sensitive ...

Quest Diagnostics’ COVID testing revenues dropped more than 55% year over year—from $709 million in the third quarter of 2021 to $316 million this year. (Quest Diagnostics) Though countless diagnostic ...

Our indicative theme of Covid-19 Testing Stocks– which includes the stocks of companies that produce or carry out tests for the highly infectious virus – is up by about 51% year-to-date, on an equally ...